← Back
$IRON All transactions

Disc Medicine, Inc.

▼ SELL

$ Value

$323K

Shares

3,446

Price

$94

Filed

Dec 16

Insider

Name

Bitterman Kevin

Title

CIK

0001591747

Roles

Director

Transaction Details

Transaction Date

2025-12-12

Code

S

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

418,335

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.5289 to $92.4325 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), (4), (7), (8), (9) and (10). | These shares are held by Atlas Venture Opportunity Fund I, LP ("Opportunity I"). The general partner of Opportunity I is Atlas Venture Associates Opportunity I, LP ("Associates I"). Atlas Venture Associates Opportunity I, LLC ("Associates I LLC") is the general partner of Associates I. The Reporting Person is a member of Associates I LLC and disclaims beneficial ownership of such securities held by Opportunity I, except to the extent of his pecuniary interest therein, if any. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.52 to $93.3796 inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.52 to $94.255 inclusive. | These shares are held by Atlas Venture Opportunity Fund II, LP ("Opportunity II"). The general partner of Opportunity II is Atlas Venture Associates Opportunity II, LP ("Associates II"). Atlas Venture Associates Opportunity II, LLC ("Associates II LLC") is the general partner of Associates II. The Reporting Person is a member of Associates II LLC and disclaims beneficial ownership of such securities held by Opportunity II, except to the extent of his pecuniary interest therein, if any. | These shares are held by Atlas Venture Fund XII, L.P. ("Atlas XII"). The general partner of Atlas XII is Atlas Venture Associates XII, L.P. ("Associates XII"). Atlas Venture Associates XII, LLC ("Associates XII LLC") is the general partner of Associates XII. The Reporting Person is a member of Associates XII LLC and disclaims beneficial ownership of such securities held by Atlas XII, except to the extent of his pecuniary interest therein, if any. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.99 inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.00 to $92.48 inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.79 to $91.95 inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.705 inclusive. | Fully Vested.

Filing Info

Accession No.

0001104659-25-121740

Form Type

4

Issuer CIK

0001816736

Bitterman Kevin's History

Date Ticker Type Value
2025-12-17 IRON $36K
2025-12-17 IRON $19K
2025-12-17 IRON $14K
2025-12-16 IRON $3.3M
2025-12-16 IRON $1.7M
2025-12-16 IRON $1.3M
2025-12-15 IRON $2.6M
2025-12-15 IRON $361K
2025-12-15 IRON $1.4M
2025-12-15 IRON $189K

Other Insiders at IRON (90d)

Insider Bought Sold Last
Franchi Jean M.
Chief Financial Officer
$461K 2026-04-14
Savage William Jacob
Chief Medical Officer
$380K 2026-04-13